Exhibit 99.1
Aspyra Reports Results of Operations for the Third Quarter Ended
September 30, 2006
CALABASAS, Calif.--(BUSINESS WIRE)--Nov. 14, 2006--Aspyra, Inc.
(AMEX:APY), a provider of clinical and diagnostic information systems
for the healthcare industry, today announced its results of operations
for the third quarter ended September 30, 2006.
Sales were $3,282,041 for the third quarter compared with sales of
$1,727,672 for the comparable quarter ended September 30, 2005. The
Company incurred a net loss of $710,063, or basic and diluted loss per
share of $.07 for the quarter ended September 30, 2006, compared with
a net loss of $1,073,152, or basic and diluted loss per share of $.31
for the comparable quarter ended September 30, 2005. Basic and diluted
shares outstanding for each period were 10,772,914 and 3,465,900,
respectively.
Sales were $9,201,937 for the nine months ended September 30,
2006, compared with sales of $5,108,967 for the nine months ended
September 30, 2005. The Company incurred a net loss of $3,087,961, or
basic and diluted loss per share of $.32 for the nine months ended
September 30, 2006 compared with a net loss of $1,498,654, or basic
and diluted loss per share of $.44 for the comparable nine-month
period ended September 30, 2005. Basic and diluted shares outstanding
for each period were 9,625,505 and 3,401,011, respectively.
Steven M. Besbeck, Aspyra's President and Chief Executive Officer,
stated, "Our results of operations for the third quarter show a marked
improvement in operating results as compared to the first and second
fiscal quarters of 2006. As we complete the integration plans of our
businesses, we significantly reduced our operating losses in the third
quarter. Our improved operating results are also indicative of the
improvement in our ability to complete installations of our products
on a more timely basis and to recognize revenues from such
transactions which have been delayed in prior periods primarily due to
third party issues. During the quarter we closed new orders for
laboratory, PACS, and radiology systems, and anticipate installing
them in a timely manner."
About Aspyra
Aspyra is a global provider of Health Care Information Technology
(HCIT) solutions and services to the healthcare industry. The Company
specializes in Clinical Information Systems (CIS), Picture Archive
Communication Systems (PACS) and Clinical Image Management Systems
(CIMS) for hospitals, multi-specialty clinics, clinical laboratories,
imaging departments and centers, orthopedic environments and
pharmacies. Aspyra's highly scalable systems can be installed
standalone or integrated to provide a single-vendor, enterprise-wide
solution. For more information on Aspyra, its products and services,
visit www.aspyra.com.
Safe Harbor Statement
This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to anticipated revenues, expenses,
earnings, operating cash flows, the outlook for Aspyra's markets and
the demand for its products. Forward-looking statements are not
guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today, November
14, 2006, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: whether the combined company will
realize the potential benefits of the merger; the competitive
environment; unexpected technical and marketing difficulties inherent
in major product development efforts; the potential need for changes
in our long-term strategy in response to future developments; future
advances in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.
Consolidated Statement of Operations
Third Quarter Ended Nine Months Ended
September 30, September 30,
2006 2005 2006 2005
----------- ----------- ----------- -----------
Net Sales $ 3,282,041 $ 1,727,672 $ 9,201,937 $ 5,108,967
Net Loss $ (710,063) $(1,073,152) $(3,087,961) $(1,498,654)
Net Loss per
Share - Basic
and Diluted $ (0.07) $ (0.31) $ (0.32) $ (0.44)
Average Shares
Outstanding -
Basic and
Diluted 10,772,914 3,465,900 9,625,505 3,401,011
CONTACT: Aspyra, Inc.
Steven M. Besbeck, President and CEO
818-880-6700, x8660
or
The Wall Street Group, Inc.
Ron Stabiner, 212-888-4848